paclitaxel has been researched along with Charcot-Marie-Tooth Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (12.50) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 2 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abyzov, A; Banck, MS; Beutler, AS; Kanwar, R; Le-Rademacher, JG; Lopez, CL; Loprinzi, CL; Major-Elechi, B; Sloan, JA; Therneau, TM | 1 |
| Beutler, AS; Chen, Y; Fang, F; Gersch, CL; Hayes, DF; Henry, NL; Hertz, DL; Kidwell, KM; Lavoie Smith, EM; Marcath, LA; Rae, JM; Vangipuram, K | 1 |
| Hayashi, T; Irie, K; Kimura, N; Kochi, A; Matsuo, K; Mishima, K; Myose, T; Nakamura, Y; Nakano, T; Sano, K; Satho, T; Takase, Y; Yamashita, Y | 1 |
| Banck, MS; Beutler, AS; Beyerlein, P; Boora, GK; Cunningham, JM; Kanwar, R; Klein, CJ; Kulkarni, AA; Le-Lindqwister, NA; Loprinzi, CL; Qin, R; Ruddy, KJ; Schroth, GP; Smalley, RL; Therneau, TM; Windebank, AJ; Wu, Y; Züchner, S | 1 |
| Banck, MS; Behrens, RJ; Beutler, AS; Beyerlein, P; Boora, GK; Kanwar, R; Kulkarni, AA; Loprinzi, CL; Lynch, CA; Pleticha, J; Qin, R; Ruddy, KJ; Züchner, S | 1 |
| Asuncion, BR; Bandla, A; Fazreen, Z; Goh, BC; Ho, J; Hoppe, MM; Jeyasekharan, AD; Kumarakulasinghe, NB; Lee, SC; Lim, JS; Ow, SG; Pang, B; Poh, LM; Putti, TC; Soong, RC; Sundar, R; Tan, DS; Tan, SS; Wilder-Smith, EP | 1 |
| Aranda Aguilar, E; de la Haba-Rodríguez, JR; Gómez-España, MA; Ortiz-Morales, MJ | 1 |
| Grendys, EC; Martino, MA; Miller, E | 1 |
1 trial(s) available for paclitaxel and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
Genetic variation in Charcot-Marie-Tooth genes contributes to sensitivity to paclitaxel-induced peripheral neuropathy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Charcot-Marie-Tooth Disease; Cohort Studies; Female; Genetic Variation; Humans; Male; Middle Aged; Paclitaxel; Polyneuropathies; Prospective Studies | 2020 |
7 other study(ies) available for paclitaxel and Charcot-Marie-Tooth Disease
| Article | Year |
|---|---|
Neurological safety of oxaliplatin in patients with uncommon variants in Charcot-Marie-tooth disease genes.
Topics: Charcot-Marie-Tooth Disease; Exome Sequencing; Genetic Testing; Humans; Oxaliplatin; Paclitaxel | 2020 |
Involvement of Charcot-Marie-Tooth disease gene mitofusin 2 expression in paclitaxel-induced mechanical allodynia in rats.
Topics: Animals; Antineoplastic Agents, Phytogenic; Charcot-Marie-Tooth Disease; Disease Models, Animal; GTP Phosphohydrolases; Hyperalgesia; Male; Membrane Proteins; Mitochondrial Proteins; Paclitaxel; Peripheral Nervous System Diseases; Rats; Rats, Sprague-Dawley | 2017 |
Sequencing of Charcot-Marie-Tooth disease genes in a toxic polyneuropathy.
Topics: Alleles; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Charcot-Marie-Tooth Disease; Female; Humans; Male; Middle Aged; Mutation; Neoplasms; Paclitaxel; Polyneuropathies; Prospective Studies; Rho Guanine Nucleotide Exchange Factors | 2014 |
Association of the Charcot-Marie-Tooth disease gene ARHGEF10 with paclitaxel induced peripheral neuropathy in NCCTG N08CA (Alliance).
Topics: Antineoplastic Agents, Phytogenic; Case-Control Studies; Charcot-Marie-Tooth Disease; Female; Genetic Predisposition to Disease; Genotype; Humans; Male; Middle Aged; Models, Genetic; Mutation; Paclitaxel; Peripheral Nervous System Diseases; Pharmacogenetics; Polymorphism, Single Nucleotide; Rho Guanine Nucleotide Exchange Factors | 2015 |
Low Levels of NDRG1 in Nerve Tissue Are Predictive of Severe Paclitaxel-Induced Neuropathy.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Breast Neoplasms; Cell Cycle Proteins; Charcot-Marie-Tooth Disease; Female; Humans; Intracellular Signaling Peptides and Proteins; Male; Middle Aged; Nerve Tissue; Paclitaxel; Peripheral Nervous System Diseases | 2016 |
[ABCB1 polymorphisms in patients with Charcot-Marie-Tooth disease. A possible relationship with neurotoxicity due to cytostatic treatment].
Topics: Adenocarcinoma; Antineoplastic Agents; Breast Neoplasms; Charcot-Marie-Tooth Disease; Colonic Neoplasms; Cytostatic Agents; Disease Susceptibility; Female; Genotype; Humans; Multidrug Resistance-Associated Proteins; Organoplatinum Compounds; Oxaliplatin; Paclitaxel; Peripheral Nervous System Diseases; Polymorphism, Single Nucleotide | 2012 |
The administration of chemotherapy in a patient with Charcot-Marie-Tooth and ovarian cancer.
Topics: Antineoplastic Combined Chemotherapy Protocols; Charcot-Marie-Tooth Disease; Docetaxel; Female; Humans; Middle Aged; Ovarian Neoplasms; Paclitaxel; Taxoids | 2005 |